Pillay D - Search Results

1

Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.

Gupta RK, Mlcochova P, Pelchen-Matthews A, Petit SJ, Mattiuzzo G, Pillay D, Takeuchi Y, Marsh M, Towers GJ. Gupta RK, et al. Among authors: pillay d. Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20889-94. doi: 10.1073/pnas.0907075106. Epub 2009 Oct 28. Proc Natl Acad Sci U S A. 2009. PMID: 19864625 Free PMC article.

2

Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups.

Hué S, Pillay D, Clewley JP, Pybus OG. Hué S, et al. Among authors: pillay d. Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4425-9. doi: 10.1073/pnas.0407534102. Epub 2005 Mar 14. Proc Natl Acad Sci U S A. 2005. PMID: 15767575 Free PMC article.

3

HIV resistance and the developing world.

Gupta RK, Pillay D. Gupta RK, et al. Among authors: pillay d. Int J Antimicrob Agents. 2007 May;29(5):510-7. doi: 10.1016/j.ijantimicag.2007.01.003. Epub 2007 Mar 7. Int J Antimicrob Agents. 2007. PMID: 17346940 Review.

4

Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials.

Gupta R, Hill A, Sawyer AW, Pillay D. Gupta R, et al. Among authors: pillay d. Clin Infect Dis. 2008 Sep 1;47(5):712-22. doi: 10.1086/590943. Clin Infect Dis. 2008. PMID: 18662137

5

Management of paediatric HIV-1 resistance.

Gupta RK, Gibb DM, Pillay D. Gupta RK, et al. Among authors: pillay d. Curr Opin Infect Dis. 2009 Jun;22(3):256-63. doi: 10.1097/qco.0b013e3283298f1f. Curr Opin Infect Dis. 2009. PMID: 19405216 Free PMC article. Review.

6

Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.

Gupta RK, Hué S, Schaller T, Verschoor E, Pillay D, Towers GJ. Gupta RK, et al. Among authors: pillay d. PLoS Pathog. 2009 May;5(5):e1000443. doi: 10.1371/journal.ppat.1000443. Epub 2009 May 22. PLoS Pathog. 2009. PMID: 19461879 Free PMC article.

7

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.

Gupta RK, Hill A, Sawyer AW, Cozzi-Lepri A, von Wyl V, Yerly S, Lima VD, Günthard HF, Gilks C, Pillay D. Gupta RK, et al. Among authors: pillay d. Lancet Infect Dis. 2009 Jul;9(7):409-17. doi: 10.1016/S1473-3099(09)70136-7. Lancet Infect Dis. 2009. PMID: 19555900

8

Gag determinants of fitness and drug susceptibility in protease inhibitor-resistant human immunodeficiency virus type 1.

Parry CM, Kohli A, Boinett CJ, Towers GJ, McCormick AL, Pillay D. Parry CM, et al. Among authors: pillay d. J Virol. 2009 Sep;83(18):9094-101. doi: 10.1128/JVI.02356-08. Epub 2009 Jul 8. J Virol. 2009. PMID: 19587031 Free PMC article.

9

Causes and consequences of incomplete HIV RNA suppression in clinical trials.

Pozniak A, Gupta RK, Pillay D, Arribas J, Hill A. Pozniak A, et al. Among authors: pillay d. HIV Clin Trials. 2009 Sep-Oct;10(5):289-98. doi: 10.1310/hct1005-289. HIV Clin Trials. 2009. PMID: 19906623 Review.

10

Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine.

Gupta RK, Ford D, Mulenga V, Walker AS, Kabamba D, Kalumbi M, Grant PR, Ferrier A, Pillay D, Gibb DM, Chintu C. Gupta RK, et al. Among authors: pillay d. Pediatr Infect Dis J. 2010 Aug;29(8):e57-62. doi: 10.1097/INF.0b013e3181e47609. Pediatr Infect Dis J. 2010. PMID: 20508547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

737 results

Search Page

Filters